发明名称 |
PHARMACEUTICAL FORMULATION FOR INTRAVENOUS OR INTRAMUSCULAR OCTREOTIDE ADMINISTRATION |
摘要 |
<p>A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2. <IMAGE></p> |
申请公布号 |
EP1153615(B1) |
申请公布日期 |
2003.02.26 |
申请号 |
EP20000985268 |
申请日期 |
2000.12.15 |
申请人 |
LIPOTEC, S.A. |
发明人 |
PONSATI OBIOLS, BERTA;JODAS FARRES, GEMMA;CLEMENTE RODRIGUEZ, FRANCISCO JAVIER;PAVON FERNANDEZ, SERGI;BACARDIT CABADO, JORDI |
分类号 |
A61K9/08;A61K38/00;A61K38/12;A61K38/31;A61K47/02;A61K47/10;A61K47/18;A61P1/04;(IPC1-7):A61K47/18 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|